Concepedia

William P. Feeney

WP

Statistics

Publications

43

Citations

2.5K

H-Index

27

Active since

1972

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

West Virginia University

National Institute of Standards and Technology

University of Pennsylvania

William P. Feeney is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and medicinal chemistry.

ORCID

Publications per year

1972–2024

43

Publications

43

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 491 citations · Full text

, , +12

Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo

G C Koo, Joseph T. Blake, Althea Talento et al. · The Journal of Immunology · 1997 · 219 citations · Full text

, , +17

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Linda Brockunier, Emma R. Parmee, Hyun Ok et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 199 citations · Full text

, , +6

Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8.

Roger Meurer, Gail Van Riper, William P. Feeney et al. · The Journal of Experimental Medicine · 1993 · 171 citations · Full text

, , +17

Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585

Gerard J. Hickey, Jennifer E. Drisko, Terry D. Faidley et al. · Journal of Endocrinology · 1996 · 99 citations

, , +17

1–5 of 43